KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Non-cash Items (2017 - 2018)

Historic Non-cash Items for Alnylam Pharmaceuticals (ALNY) over the last 9 years, with Q4 2018 value amounting to $149.5 million.

  • Alnylam Pharmaceuticals' Non-cash Items rose 272429.17% to $149.5 million in Q4 2018 from the same period last year, while for Dec 2018 it was $149.5 million, marking a year-over-year increase of 272429.17%. This contributed to the annual value of $149.5 million for FY2018, which is 272429.17% up from last year.
  • Alnylam Pharmaceuticals' Non-cash Items amounted to $149.5 million in Q4 2018, which was up 272429.17% from $5.3 million recorded in Q4 2017.
  • Over the past 5 years, Alnylam Pharmaceuticals' Non-cash Items peaked at $149.5 million during Q4 2018, and registered a low of $4.7 million during Q4 2015.
  • For the 4-year period, Alnylam Pharmaceuticals' Non-cash Items averaged around $41.1 million, with its median value being $5.0 million (2014).
  • Its Non-cash Items has fluctuated over the past 5 years, first tumbled by 9864.25% in 2014, then surged by 272429.17% in 2018.
  • Quarter analysis of 4 years shows Alnylam Pharmaceuticals' Non-cash Items stood at $4.7 million in 2014, then fell by 0.78% to $4.7 million in 2015, then rose by 12.66% to $5.3 million in 2017, then surged by 2724.29% to $149.5 million in 2018.
  • Its Non-cash Items was $149.5 million in Q4 2018, compared to $5.3 million in Q4 2017 and $4.7 million in Q4 2015.